Cancerfax

CancerFax is the most trusted platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, NK Cell therapy and clinical trials. This life-saving service empowers patients to explore new frontiers in cancer treatment while providing them with comprehensive information on trial eligibility criteria, locations, and enrollment processes. Our company specializes in cancer clinical trial services, facilitating access to groundbreaking research and treatment options. We connect patients with cutting-edge trials, fostering hope and progress in the fight against cancer. With a commitment to improving lives, we’re at the forefront of advancing cancer care through clinical innovation. CancerFax and Beijing Biotech focus on manufacturing groundbreaking cellular therapies. Bioocus is not only a leading biotech company in China but also a value-chain functional enterprise with a research center, GMP facility, CDMO and technology transfer platform. We are credited with some groundbreaking clinical trials for CAR T-Cell therapy in China. At Beijing Bioocus Biotech, we're not just manufacturing CAR T -Cell therapies; we're empowering cancer centers to build their own CAR T labs. Please write to us at care@beijingbiotech.com and we shall get back to you with all the details and project plan. We undertake end-to-end project management for CAR T-Cell therapy production and distribution. This includes: 1) CAR T laboratory design and GMP guidance 2) CAR T laboratory equipment’s sourcing and supply 3) Production and marketing of CAR T Cell therapy 4) Training for biotechnicians and quality control 5) CAR T vectors supply (CD 19 and BCMA) 6) Clinical studies 7) Clinicians training 8) CAR T technology transfer